1. Company Information :
Logo société
| Company name | NEW BODY LINE |
| Date of creation | 20 November 2000 |
| Legal Form | Limited Company |
| National Company Register | B18695 |
| Sector | Personal & Household Goods |
| Special legislation | Common Law |
| Social object | Designing, developing, sewing, manufacturing, and marketing all types of clothing. |
| Corporate address | Avenue Ali Balhouane – 5199 Mahdia – Tunisia |
| Phone | +216 73 680 435 |
| Corporate Website | http://www.newbodyline.com.tn/ |
| newbodyline@planet.tn | |
| Listing date and listing modality | 30/04/2013 |
| ISIN code | TN0007540016 |
| Market | Main Market |
| Compartment | A |
| Trading Method | Continuous |
| Listing Group | 11 |
2. Shareholder Relations Officer :
| Full Name | Phone | |
|---|---|---|
| Mourad MABROUK | daf@newbodyline.com | +216 73 680 435 |
3. Administration, Management and Control
Chef Executive Officer
Mr. Karim REJEB SFAR
Board of Directors
OGM-
16/04/2025
| Name or Corporate Name | Quality | Represented by | Term of mandate |
|---|---|---|---|
| Mrs.Hanène REJEB | Chairman | himself | 2024 - 2026 |
| Mr. Nessim REJEB | Member | himself | 2024 - 2026 |
| Mr. Hédi REJEB SFAR | Member | himself | 2024 - 2026 |
| Mr. Karim REJEB SFAR | Member | himself | 2024 - 2026 |
| Mr. Hamza ABDELKADER | Member | himself | 2024 - 2026 |
| Mr. Mahmoud Hafedh SNENE | Member | himself | 2024 - 2026 |
| Mr. Sofiane BEN SLAMA | Member representing minority shareholders | himself | 2024 - 2026 |
Control
External auditors
| Full Name | Term of mandate |
|---|---|
| Univers Audit Company | 2024 - 2026 |
Committees of the Board of Directors
| Committee | Committee President |
|---|---|
4. Main Shareholders:
OGM-
16/04/2025
| Name or Corporate Name | Number of shares | % |
|---|---|---|
| Karim REJEB SFAR | 2227115 | 52.4 |
| Nessim REJEB | 469560 | 11.05 |
| Autres actionnaires détenant moins que 5% | 1553725 | 36.55 |
| Total | 4250400 | 100 |
5. Key Indicators & Ratios:
| Key figures in DT (1) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 4 250 400 | 4 250 400 | 4 250 400 |
| Book Value | 5 073 268 | 13 120 772 | 12 200 418 |
| Revenues excluding VAT | 8 856 433 | 11 131 002 | 5 448 439 |
| Operating income | -6 120 768 | 1 136 892 | 511 394 |
| Earnings (2) | -6 442 342 | 183 957 | 1 135 336 |
| Dividend per share | - | 0.300 | 0.300 |
(1) Disclosed in the consolidated annual financial statements or, failing that, in the individual annual financial statements.
(2) Net income Group share for companies publishing consolidated accounts.
(2) Net income Group share for companies publishing consolidated accounts.
| Ratio | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings per share | -1,440 | 0,267 | 0,267 |
| Dividend yield % | 6.1 | 0.9 | 10.0 |
| PBR (2) | 1.8 | 1.9 | 2.0 |
| PER (1) | 18.5 | 19.8 | 9.8 |
(1) Price Earning Ratio
(2) Price to book Value
(2) Price to book Value
6. Share Capital
Capital Structure
| Nature of Securities | Number | % | Nominal (DT) |
|---|---|---|---|
| Ordinary shares | 4250400 | 100 | 1 |
Capital Evolution
| Decision (EGM) | Nominal (DT) | Nature of the operation | Capital evolution | Capital in circulation | ||
|---|---|---|---|---|---|---|
| DT | Equities | DT | Equities | |||
| 2000-11-20 | 10 | Constitution de la Société |
600000 |
60000 |
600000 |
60000 |
| 2011-12-05 | 10 | Increase through Incorporation of Reserves |
96710 |
9671 |
696710 |
69671 |
| 2012-03-12 | 10 | Increase through Incorporation of Reserves |
3290 |
329 |
700000 |
70000 |
| 2012-05-25 | 10 | Increase through Incorporation of Reserves |
2450000 |
245000 |
3150000 |
315000 |
| 2012-05-25 | 1 | Reduction in Nominal Value |
|
|
3150000 |
3150000 |
| 2012-12-21 | 1 | Cash Increase |
630000 |
630000 |
3780000 |
3780000 |
| 2013-11-14 | 1 | Increase through Incorporation of Reserves |
84000 |
84000 |
3864000 |
3864000 |
| 2017-05-23 | 1 | Increase through Incorporation of Reserves |
386400 |
386400 |
4250400 |
4250400 |
7. Latest publications NEW BODY LINE
NEW BODY LINE - General Meeting Ordinary at 29/06/2026
General Meeting Ordinary of 29/06/2026.
NEW BODY LINE - Financial Statements Annual Consolidated at 31/12/2025
Consolidated Annual Financial Statements for the year 2025.
NEW BODY LINE - Financial Statements Annual Individual at 31/12/2025
Individual Annual Financial Statements for the year 2025.
8. The instruments of NEW BODY LINE
| Mnemonic | Label | Nature |
|---|---|---|
| NBL | NEW BODY LINE | Equity |
| NBL13 | NBL Da1/45 161213 | Right of allocation |
| NBL17 | NBL DA 1/10 280717 | Right of allocation |